ITGB1 and ovarian carcinoma: The increased expression of ITGB1 was also observed in other tumors, such as prostate cancer [34], ovarian carcinoma [35], lung cancer [36], colorectal adenocarcinomas [37], and in triple negative breast cancer [38].